The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets

Neonatology

Volumn 93, Issue 4, 2008, Pages 263-268

  Camelo Jr , José Simon ^a   Hehre, Dorothy ^a   Devia, Carlos ^a   Camelo, Sílvia Helena Henriques ^a   Bancalari, Eduardo ^a   Suguihara, Cleide ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Hypoxemia; Newborn piglets; Pulmonary arterial hypertension; Receptor antagonist, angiotensin II

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; SODIUM CHLORIDE;

ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HEART OUTPUT; HYPOXIA; LUNG VASOCONSTRICTION; NEWBORN; NONHUMAN; PIGLET; PRIORITY JOURNAL; VASCULAR RESISTANCE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANIMALS, NEWBORN; ANOXIA; CARDIAC OUTPUT; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; HEMODYNAMICS; LOSARTAN; PULMONARY ARTERY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SWINE;

ANIMALIA;

EID: 44849115735     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000111879     Document Type: Article

References (35)

1. Liang C-S, Gavras H: Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism. J Clin Invest 1978;62:961-970.
2. Raff H, Maselli J, Reid IA: Correlation of plasma angiotensin II concentration and plasma renin activity during acute hypoxia in dogs. Clin Exp Pharmacol Physiol 1985;12:91-94.
3. Hotta J, Hanaoka M, Droma Y, Katsuyama Y, Ota M, Kobayashi T: Polymorphisms of renin-angiotensin system genes with high altitude pulmonary edema in Japanese subjects. Chest 2004;126:825-830.
4. Mattioli L, Zakheim RM, Mullis K, Molteni A: Angiotensin-I-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in mice. J Pediatr 1975;87:97-101.
5. Yeh TF: Persistent pulmonary hypertension in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 2001;Suppl 23:103-106.
6. Morrell NW, Grieshaber SS, Danilov SM, Majack RA, Stenmark KR: Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation. Am J Respir Cell Mol Biol 1996;14:326-337.
7. Chassagne C, Eddahibi S, Adamy C, Rideau D, Marotte F, Dubois-RandéJL, Adnot S, Samuel JL, Teiger E: Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 2000;22:323-332.
8. Lankford SM, Plummer D, Hellyer P, Christ DD, Bai SA: Pharmacokinetic-pharmacodynamic relations of losartan and EXP3174 in a porcine model. J Cardiovasc Pharmacol 1997;30:583-590.
9. Prechtl HFR: The behavioural states of the newborn infant (a review). Brain Res 1974;76:185-212.
10. Carr AA, Prisant LM: Losartan: first of a new class of angiotensin antagonists for the management of hypertension. J Clin Pharmacol 1996;36:3-12.
11. Sasaki M, Fujimura A, Harada K, Sunaga K, Ebihara A: Clinical pharmacology of multiple-dose Losartan, an angiotensin II receptor antagonist, in patients with essential hypertension. J Clin Pharmacol 1996;36:403-408.
12. Chiu AT, McCall DE, Price WA Jr, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB: In vitro pharmacology of Dup 753. Am J Hypertens 1991;4:282S-287S.
13. Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB: In vivo pharmacology of Dup 753. Am J Hypertens 1991;4:288S-298S.
14. Kiely DG, Cargill RI, Lipworth BJ: Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. Cardiovasc Res 1995;30:875-880.
15. Kiely DG, Cargill RI, Lipworth BJ: Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. Chest 1996;110:698-703.
16. Zhao L, Al-Tubuly R, Sebkhi A, Owji AA, Nunez DJR, Wilkins MR: Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol 1996;119:1217-1222.
17. Cody RJ: The integrated effects of angiotensin II. Am J Cardiol 1997;79:9-11.
18. Samyn ME, Petershack JA, Bedell KA, Mathews MS, Segar JL: Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep. Pediatr Res 1998;44:323-329.
19. Cox BE, Liu X-T, Fluharty SJ, Rosenfeld CR: Vessel-specific regulation of angiotensin II receptor subtypes during ovine development. Pediatr Res 2005;57:124-132.
20. Morrell NW, Morris KG, Stenmark KR: Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995;269:H1186-H1194.
21. Kuba K, Imai Y, Penninger JM: Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol 2006;6:271-276.
22. Olson S, Oeckler R, Li X, Du L, Traganos F, Zhao X, Burke-Wolin T: Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Am J Physiol Lung Cell Mol Physiol 2004;287:L559-L568.
23. Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T: Angiotensin II AT 1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 2002;40:521-527.
24. Ye S, Zhong H, Duong VN, Campese VM: Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002;39:1101-1106.
25. 2 receptor. J Pharmacol Exp Ther 2003;307:1171-1178.
26. Abadir PM, Carey RM, Siragy HM: Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003;42:600-604.
27. Zakheim RM, Molteni A, Mattioli L, Park M: Plasma angiotensin II levels in hypoxic and hypovolemic stress in unanesthetized rabbits. J Appl Physiol 1976;41:462-465.
28. Krebs MO, Boemke W, Simon S, Wenz M, Kaczmarczyk G: Acute hypoxic pulmonary vasoconstriction in conscious dogs decreases renin and is unaffected by losartan. J Appl Physiol 1999;86:1914-1919.
29. Cargill RI, Lipworth BJ: Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 1996;109:424-429.
30. Young KC, Ladino J, Navarrette C, Dabrowska K, Hehre D, Bancalari E, Suguihara C: The effect of a nebulized NO donor, DPTA/NO, on acute hypoxic pulmonary hypertension in newborn piglets. Biol Neonate 2004;85:195-202.
31. Fike CD, Zhang Y, Kaplowitz MR: Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets. J Appl Physiol 2005;99:670-676.
32. Ryckwaert F, Colson PH: Hypovolaemia-induced vasodilatation during angiotensin AT1 receptor blockade: role of the AT2 receptor. Pharmacol Res 2005;51:37-40.
33. Francis RCE, Holme C, Kaczmarczyk G, Boemke W: Effect of angiotensin II and endothelin-1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs. Acta Physiol Scand 2004;180:319-328.
34. Kumar VH, Hutchison AA, Lakshminrusinha S, Morin FC III, Wynn RJ, Ryan RM: Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 2007;27:214-219.
35. Danhaive O, Margossian R, Geva T, Kourembanas S: Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J Perinatol 2005;25:495-499.